NYSE : DVA

DaVita Inc.

$236.97 USD

$2.96 (1.26%)

Volume
391.78K
Average Volume
878.04K
Market Capitalization
$15.21B
P/E Ratio
23.35
Dividend Yield
0.00%
Price Target
$235.00
Year High
$239.64
Year Low
$101.00
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$1.42
Source Headline
DaVita HealthCare (DVA) Advances While Market Declines: Some Information for Investors

DaVita HealthCare (DVA) reached $236.97 at the closing of the latest trading day, reflecting a +1.26% change compared to its last close.

zacks.com - 2026-07-17 19:01:05

DaVita HealthCare (DVA) Rises As Market Takes a Dip: Key Facts

In the closing of the recent trading day, DaVita HealthCare (DVA) stood at $234.01, denoting a +1.04% move from the preceding trading day.

zacks.com - 2026-07-16 19:16:06

DaVita: I Believe This Is Overvalued

DaVita Inc. has more than doubled in share price within six months, driven by a strong Q1 '26 beat and a favorable court ruling. DVA fundamentals and long-term prospects remain largely unchanged, with 2026E AEPS recovery now expected at 30%+ and 10–16% annualized growth through 2028. I sold over 95% of my DVA position as the valuation exceeded $210/share, far above my fair value target of $130/share.

seekingalpha.com - 2026-07-15 12:14:30

DaVita HealthCare (DVA) Laps the Stock Market: Here's Why

In the closing of the recent trading day, DaVita HealthCare (DVA) stood at $232.8, denoting a +1.45% move from the preceding trading day.

zacks.com - 2026-07-10 19:01:08

Everyone Is Watching Greg Abel. But Another Berkshire Hathaway Stock Picker Is Quietly Winning in 2026.

Greg Abel may have taken over as CEO, but he's not the only one making key investment decisions at Berkshire Hathaway. Berkshire's positions in DaVita and SiriusXM, reportedly selected by Ted Weschler, who manages a portion of the portfolio, have outperformed so far in 2026.

fool.com - 2026-07-09 18:30:00

DaVita HealthCare (DVA) Suffers a Larger Drop Than the General Market: Key Insights

DaVita HealthCare (DVA) reached $230.72 at the closing of the latest trading day, reflecting a -1.53% change compared to its last close.

zacks.com - 2026-07-08 19:16:06

Top 5 Non-AI S&P 500 Stock Picks for 2H 2026 That Have Surged in 1H

ADM, CASY, DVA, CVS and BEN top a list of five non-AI S&P 500 stocks that surged more than 30% in 1H 2026 and still show momentum for 2H.

zacks.com - 2026-07-03 09:55:53

DaVita Inc (DVA) Stock Up 3.0% but GF Value Says Overvalued -- GF Score: 88/100

On July 02, 2026, DaVita Inc (DVA) shares rose 3.0% to a current price of $234.91. The stock has experienced significant price appreciation recently, with a 10.

gurufocus.com - 2026-07-02 20:22:00

Should Value Investors Buy DaVita (DVA) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

zacks.com - 2026-07-02 10:40:35

Best Growth Stocks to Buy for July 2nd

DVA, FIVE, and PBI it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 2, 2026.

zacks.com - 2026-07-02 03:55:31

DaVita Stock Benefits From Strengthening Kidney Care Delivery

DVA is advancing kidney care through IKC expansion, CMS CKCC progress and AI-driven dialysis scheduling improvements.

zacks.com - 2026-06-30 14:11:07

Best Growth Stocks to Buy for June 30th

DVA, FIVE, and PBI it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 30, 2026.

zacks.com - 2026-06-30 05:31:08

Here's Why DaVita HealthCare (DVA) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

zacks.com - 2026-06-29 10:40:37

Why the Market Dipped But DaVita HealthCare (DVA) Gained Today

In the most recent trading session, DaVita HealthCare (DVA) closed at $217.04, indicating a +1.72% shift from the previous trading day.

zacks.com - 2026-06-26 19:02:07

If You Own These 10 Stocks — Analysts Think You Should Sell Them

Analysts don't like to put "sell" ratings on S&P 500 stocks. So the fact they're willing to do it with some is worth your attention.

investors.com - 2026-06-26 07:12:06

Best Growth Stocks to Buy for June 26th

LYB, HRB and DVA made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 26th, 2026.

zacks.com - 2026-06-26 05:31:04

DaVita HealthCare (DVA) Ascends While Market Falls: Some Facts to Note

The latest trading day saw DaVita HealthCare (DVA) settling at $213.04, representing a +1% change from its previous close.

zacks.com - 2026-06-24 19:16:23

DaVita Stock Benefits From Expanding Community-Based Kidney Care

DVA is expanding kidney care through outpatient, home-centered and value-based programs while investing in AI-enabled scheduling.

zacks.com - 2026-06-24 13:05:26

Best Growth Stocks to Buy for June 24th

HRB, DVA and PBI made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 24th, 2026.

zacks.com - 2026-06-24 04:46:05

DVA vs. FMS: Which Dialysis Leader Is Better Positioned Now?

DaVita and Fresenius Medical Care are taking different paths in kidney care, but which stock offers stronger upside now? Let's dive in.

zacks.com - 2026-06-23 14:21:09

3 Medical Stocks to Bet on Amid Market Optimism Following SpaceX IPO

Medical stocks like Centene, DaVita and BrightSpring could rally as SpaceX IPO-fueled market optimism lifts broader sector sentiment.

zacks.com - 2026-06-22 11:31:47

Best Growth Stocks to Buy for June 22nd

HRB, DVA and PBI made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 22nd, 2026.

zacks.com - 2026-06-22 06:05:21

DaVita HealthCare (DVA) Stock Dips While Market Gains: Key Facts

DaVita HealthCare (DVA) closed the most recent trading day at $207.91, moving 1.27% from the previous trading session.

zacks.com - 2026-06-18 19:01:05

4 Stocks Trading Near 52-Week High With Room to Rise Further

Investors target stocks that have been on a bullish run. Stocks like MUSA, DVA, HPE and VSH are seeing price strength, and the momentum is likely to continue.

zacks.com - 2026-06-18 12:31:12

DaVita Expands Specialized Care Beyond Acute Settings Through IKC

DVA is expanding kidney care beyond hospitals with IKC, digital tools and AI to improve coordination, lower costs and support patients.

zacks.com - 2026-06-17 12:21:12

Best Value Stocks to Buy for June 17th

ECPG, DK and DVA made it to the Zacks Rank #1 (Strong Buy) value stocks list on June 17, 2026.

zacks.com - 2026-06-17 04:51:06

Best Growth Stocks to Buy for June 17th

DVA, FIVE, and PBI it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 17, 2026.

zacks.com - 2026-06-17 04:36:08

DaVita vs. Encompass Health: Which Healthcare Stock Is a Better Buy in 2026?

DaVita operates more than 3,200 dialysis centers globally, serving roughly 295,000 patients with a dominant market share in kidney care. Encompass Health is a leader in inpatient rehabilitation with double-digit revenue growth and higher net margins than its peer in this matchup.

fool.com - 2026-06-15 14:10:52

Best Growth Stocks to Buy for June 15th

DVA, FIVE, and PBI it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 15, 2026.

zacks.com - 2026-06-15 04:26:05

Banking Giant, Three Other Top Stocks Make New Highs As Market Aims To Rebound

Banking giant BMO, Astronics, DaVita and Intercorp Financial make new highs Friday as the stock market aims to rebound.

investors.com - 2026-06-12 13:57:49

DaVita HealthCare (DVA) Exceeds Market Returns: Some Facts to Consider

In the most recent trading session, DaVita HealthCare (DVA) closed at $203.83, indicating a +2.66% shift from the previous trading day.

zacks.com - 2026-06-11 19:01:08

DaVita HealthCare (DVA) Moves to Strong Buy: Rationale Behind the Upgrade

DaVita HealthCare (DVA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

zacks.com - 2026-06-11 13:01:09

Best Value Stocks to Buy for June 11th

PRTH, DVA and BFH made it to the Zacks Rank #1 (Strong Buy) value stocks list on June 11, 2026.

zacks.com - 2026-06-11 04:55:10

Best Growth Stocks to Buy for June 11th

DVA, HRB, and PBI it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 11, 2026.

zacks.com - 2026-06-11 04:46:06

DaVita Stock Gains From Integrated Kidney Care and CKCC Progress

DVA expands its IKC platform, tops CKCC savings in first-quarter 2026 and rolls out AI ScheduleHub to boost scheduling and staffing.

zacks.com - 2026-06-10 13:56:05

Are Investors Undervaluing DaVita (DVA) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

zacks.com - 2026-06-10 10:41:13

4 Outpatient Home Health Stocks Benefiting From Industry Trends

An aging population and rising telehealth and AI adoption boost demand in the Zacks Medical - Outpatient and Home Healthcare industry. DGX, DVA, LFST and AVAH stand to benefit.

zacks.com - 2026-06-09 11:41:06

Best Growth Stocks to Buy for June 9th

DVA, XPO, and PBI it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 9, 2026.

zacks.com - 2026-06-09 07:26:05

Best Value Stocks to Buy for June 9th

THG, DVA and PLOW made it to the Zacks Rank #1 (Strong Buy) value stocks list on June 9, 2026.

zacks.com - 2026-06-09 06:15:18

DaVita Expands Comprehensive Kidney Care Through Dialysis Services

DVA expands kidney-care reach with integrated CKD/ESKD coordination and 2026 AI scheduling tech to boost dialysis efficiency.

zacks.com - 2026-06-04 14:46:13

DaVita HealthCare (DVA) Up 0.6% Since Last Earnings Report: Can It Continue?

DaVita HealthCare (DVA) reported earnings 30 days ago. What's next for the stock?

zacks.com - 2026-06-04 12:36:47

Best Growth Stocks to Buy for June 4th

HRB, DVA and VLO made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 4th, 2026.

zacks.com - 2026-06-04 06:35:29

DaVita Gains 21.4% in Three Months: How Should You Play the Stock?

DVA raises guidance on stronger dialysis volumes and reimbursement gains, but rising patient-care and technology costs could squeeze margins.

zacks.com - 2026-06-03 14:31:24

Best Growth Stocks to Buy for June 2nd

HRB, DVA and LCUT made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 2nd, 2026.

zacks.com - 2026-06-02 06:21:17

Why DaVita HealthCare (DVA) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

zacks.com - 2026-05-29 10:50:35

Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

zacks.com - 2026-05-27 10:40:31

Best Growth Stocks to Buy for May 26th

CNC, SANM and DVA made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 26, 2026.

zacks.com - 2026-05-26 11:46:07

New Strong Buy Stocks for May 26th

LCUT, GECC, ARKO, PBI and DVA have been added to the Zacks Rank #1 (Strong Buy) List on May 26, 2026.

zacks.com - 2026-05-26 06:26:08

Is DaVita (DVA) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

zacks.com - 2026-05-25 10:41:16

4 High-Growth GARP Stocks With Attractive PEG Ratios for 2026

These four GARP stocks combine discounted PEG ratios with strong growth potential, offering investors a balanced strategy for 2026.

zacks.com - 2026-05-22 16:01:10

Get DVA Insider Trade Alerts

DVA Price Target Summary

Last Month

$246.00

3 analysts

Last Quarter

$226.17

6 analysts

Last Year

$187.92

13 analysts

All Time

$168.95

19 analysts

DVA Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2026-07-14 Truist Securities Maintain Hold Hold
2026-07-10 UBS Maintain Buy Buy
2026-07-09 Barclays Maintain Equal Weight Equal Weight
2026-05-11 TD Cowen Maintain Hold Hold
2026-05-08 Truist Securities Maintain Hold Hold
2026-05-08 Barclays Maintain Equal Weight Equal Weight
2026-05-07 UBS Maintain Buy Buy
2026-05-06 Deutsche Bank Upgrade Hold Buy
2026-02-04 UBS Maintain Buy Buy
2026-02-03 Barclays Maintain Equal Weight Equal Weight
2025-11-03 TD Cowen Maintain Hold Hold
2025-10-30 Barclays Maintain Equal Weight Equal Weight
2025-10-09 Barclays Maintain Equal Weight Equal Weight
2025-09-10 B of A Securities Maintain Underperform Underperform
2025-08-07 Barclays Maintain Equal Weight Equal Weight
2025-05-19 Truist Securities Maintain Hold Hold
2025-02-18 Barclays Maintain Equal Weight Equal Weight
2024-10-31 Barclays Maintain Equal Weight Equal Weight
2024-10-07 Truist Securities Maintain Hold Hold
2024-08-20 Truist Securities Maintain Hold Hold
2024-08-08 UBS Maintain Buy Buy
2024-08-07 B of A Securities Maintain Underperform Underperform
2024-07-24 TD Cowen Maintain Hold Hold
2024-05-15 Truist Securities Maintain Hold Hold
2024-05-06 Barclays Maintain Equal Weight Equal Weight
2024-02-20 Truist Securities Maintain Hold Hold
2024-02-15 UBS Maintain Buy Buy
2024-02-14 UBS Maintain Buy Buy
2024-02-14 Truist Securities Maintain Hold Hold
2023-11-17 UBS Maintain Buy Buy
2023-10-11 Truist Securities Maintain Hold Hold
2023-08-07 UBS Upgrade Neutral Buy
2023-07-13 Truist Securities Maintain Hold Hold
2023-05-15 Bernstein Maintain Market Perform Market Perform
2023-05-09 B of A Securities Maintain Underperform Underperform
2023-05-09 Truist Securities Maintain Hold Hold
2023-05-09 Deutsche Bank Maintain Hold Hold
2023-05-09 TD Cowen Maintain Market Perform Market Perform
2023-02-23 Truist Securities Maintain Hold Hold
2023-02-23 Cowen & Co. Maintain Outperform Outperform
2022-10-31 UBS Downgrade Buy Neutral
2022-10-31 Truist Securities Maintain Hold Hold
2022-10-31 Barclays Maintain Equal Weight Equal Weight
2022-08-19 UBS Upgrade Neutral Buy
2022-08-04 Barclays Maintain Equal Weight Equal Weight
2022-08-02 Deutsche Bank Maintain Buy Buy
2022-06-22 Truist Securities Maintain Hold Hold
2022-01-05 Truist Securities Maintain Hold Hold
2021-10-29 RBC Capital Maintain Sector Perform Sector Perform
2021-10-13 Truist Securities Maintain Hold Hold
2021-09-10 Cowen & Co. Maintain Market Perform Perform
2021-08-12 Barclays Downgrade Overweight Equal Weight
2021-07-19 Deutsche Bank Maintain Buy Buy
2021-03-26 B of A Securities Downgrade Neutral Underperform
2021-01-05 B of A Securities Downgrade Buy Neutral
2020-05-06 SunTrust Robinson Humphrey Maintain Hold Hold
2020-04-13 SunTrust Robinson Humphrey Maintain Hold Hold
2020-01-24 Goldman Sachs Upgrade Neutral Buy
2019-12-20 JP Morgan Maintain Neutral Neutral
2019-12-18 SunTrust Robinson Humphrey Maintain Hold Hold
2019-11-19 Barclays Maintain Overweight Overweight
2019-11-07 Raymond James Downgrade Outperform Market Perform
2019-11-06 Baird Maintain Neutral Neutral
2019-09-11 William Blair Downgrade Outperform Market Perform
2019-08-22 UBS Maintain Neutral Neutral
2019-07-26 Baird Downgrade Outperform Neutral
2019-05-09 Deutsche Bank Maintain Buy Buy
2019-01-08 UBS Upgrade Sell Neutral
2019-01-03 Deutsche Bank Maintain Buy Buy
2018-12-14 Barclays Maintain Overweight Overweight
2018-11-28 Raymond James Upgrade Market Perform Outperform
2018-11-16 UBS Maintain Sell Sell
2018-11-08 Raymond James Downgrade Strong Buy Market Perform
2018-11-08 RBC Capital Maintain Sector Perform Sector Perform
2018-09-13 JP Morgan Upgrade Underweight Neutral
2018-01-04 Bank of America Upgrade Neutral Buy
2018-01-04 B of A Securities Upgrade Neutral Buy
2017-12-11 Citigroup Upgrade Neutral Buy
2017-12-07 Raymond James Upgrade Outperform Strong Buy
2017-11-08 Bank of America Maintain Neutral Neutral
2017-11-08 B of A Securities Maintain Neutral Neutral
2017-10-09 JP Morgan Downgrade Neutral Underweight
2017-06-26 Jefferies Downgrade Buy Hold
2016-12-13 Baird Downgrade Outperform Neutral
2016-09-20 Raymond James Upgrade Market Perform Outperform
2016-09-06 Citigroup Maintain Neutral Neutral
2016-09-06 Bank of America Downgrade Buy Neutral
2016-09-06 B of A Securities Downgrade Buy Neutral
2016-08-09 JP Morgan Maintain Neutral Neutral
2016-03-02 Bernstein Maintain Market Perform Market Perform
2015-09-16 JP Morgan Maintain Neutral Neutral
2015-04-27 Baird Upgrade Neutral Outperform
2015-03-13 Deutsche Bank Maintain Hold Hold
2014-11-07 JP Morgan Maintain Overweight Overweight
2014-09-17 KeyBanc Downgrade Buy Hold
2014-09-17 Keybanc Downgrade Buy Hold
2014-08-15 Deutsche Bank Downgrade Buy Hold
2014-07-21 Raymond James Downgrade Outperform Market Perform
2014-06-30 Jefferies Maintain Buy Buy
2014-05-02 Deutsche Bank Maintain Buy Buy
2014-04-17 Citigroup Maintain Neutral Neutral
2014-01-06 Raymond James Upgrade Market Perform Outperform
2013-12-18 KeyBanc Maintain Buy Buy
2013-12-17 KeyBanc Maintain Buy Buy
2013-11-25 Deutsche Bank Maintain Buy Buy
2013-11-25 Citigroup Maintain Neutral Neutral
2013-10-10 Atlantic Equities Maintain Overweight Overweight
2013-08-07 RBC Capital Downgrade Outperform Sector Perform
2013-07-16 Goldman Sachs Downgrade Neutral Sell
2013-07-02 Raymond James Downgrade Outperform Market Perform
2013-04-02 Deutsche Bank Upgrade Hold Buy
2013-03-11 SunTrust Robinson Humphrey Downgrade Buy Neutral
2013-03-07 Deutsche Bank Downgrade Buy Hold
2013-02-15 B of A Securities Maintain Buy Buy
2013-02-15 Bank of America Maintain Buy Buy
2013-02-15 Goldman Sachs Downgrade Buy Neutral
2013-01-28 Bernstein Maintain Market Perform Perform
2012-12-20 JP Morgan Maintain Overweight Overweight
2012-11-06 Deutsche Bank Maintain Buy Buy
2012-10-31 Feltl & Co. Maintain Buy Buy
2012-10-11 Bank of America Maintain Buy Buy
2012-10-11 B of A Securities Maintain Buy Buy
2012-10-02 Bank of America Maintain Buy Buy
2012-10-02 B of A Securities Maintain Buy Buy
2012-08-02 Feltl & Co. Maintain Buy Buy
2012-07-03 B of A Securities Maintain Buy Buy
2012-07-03 Bank of America Maintain Buy Buy
2012-05-03 Feltl & Co. Downgrade Strong Buy Buy
2012-04-05 B of A Securities Maintain Buy Buy
2012-04-05 Bank oferica Maintain Buy Buy
2012-02-17 Goldman Sachs Maintain Buy Buy
2012-02-17 Citigroup Maintain Neutral Neutral